Astellas Pharma Inc. (ALPMF) has a market capitalization of $29.61B and trades at $16.53. The 52-week range is 8.4-17.6.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.6, Earnings Per Share (EPS) of $28.35, annual revenue of $1.91T.
The stock has a beta of 0.15, a last dividend of $0.4569, operates in the Healthcare sector.
